Article Details

Istari Oncology Announces First Patient Dosed in the LUMINOS-102 Phase 2 Clinical Trial of ...

Retrieved on: 2021-03-31 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Istari Oncology Announces First Patient Dosed in the LUMINOS-102 Phase 2 Clinical Trial of .... View article details on hiswai:

Excerpt

Istari Oncology, Inc., a clinical-stage biotechnology company, today ... viral immunotherapy that activates the innate and adaptive immune system to ...

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo